Aspire Biopharma Holdings, Inc.: Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel to Address Gastric ...

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.Clopidogrel, currently sold under the brand name Plavix, was ...

Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel (Generic Plavix(R)) to Address Gastric Bleeding Risks

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.
Medical Xpress

FDA approves expanded indication for Jaypirca

The U.S. Food and Drug Administration has approved an expanded indication for Eli Lilly's Jaypirca (pirtobrutinib), the first and only noncovalent Bruton tyrosine kinase (BTK) inhibitor for adults ...
Medical Xpress

New UK guideline for clopidogrel recommends pharmacogenetic testing for all patients before prescription

The UK Center of Excellence in Regulatory Science and Innovation in Pharmacogenomics (UK CERSI-PGx), led by the University of Liverpool, has published its first clinical guideline focused on the use ...
Courthouse News Service

Makers of blood thinner Plavix seek to quash Texas suit

Texas Attorney General Ken Paxton speaks at the Austin Police Association in Austin, Texas, in September 2020. (Jay Janner/Austin American-Statesman via AP) MARSHALL, Texas (CN) — The makers of the ...
AOL

Bristol Myers, Sanofi sued by Texas over Plavix

(Reuters) -Texas Attorney General Ken Paxton ‌sued Bristol Myers Squibb ‌and Sanofi, accusing the drugmakers of failing to disclose that ⁠Plavix,‌ which is used to prevent ‍blood clots, does not work ...
TCTMD

Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI

NEW ORLEANS, LA—Patients with atrial fibrillation (AF) who have stable coronary disease at least a year after undergoing PCI fare better when treated with direct oral anticoagulant (DOAC) monotherapy ...
Monthly Prescribing Reference

Rinvoq Receives FDA Approval for Updated IBD Indications

The updated indications state that if TNF blockers are clinically inadvisable, patients may still be administered Rinvoq if they have previously received at least 1 approved systemic therapy. The Food ...
Healio

FDA updates Rinvoq indication for use after one approved systemic therapy

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a supplemental new drug application that updates the indication statement for upadacitinib ...
Wired

This Blood Thinner Is More Effective Than Aspirin at Preventing Heart Attacks

Aspirin is one of the most widely taken medicines in the world, having been recommended for decades as a way of protecting against heart attacks and strokes in at-risk patients. However, a new study ...
Forbes

Medicines Reimagined – Repurposing Drugs For New Indications

In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...